Background
Methods
Partners/stakeholders of the project
Results
Selection criteria pathogens
ID | Pathogen(s) |
---|---|
1
| Antibiotic resistant Pseudomonas and Acinetobacter
|
2
|
Bordetella pertussis
|
3
|
Borrelia burgdorferi (Lyme disease) |
4
|
Brucella spp. |
5
|
Burkholderia cepacia complex |
6
|
Campylobacter
|
7
|
Clostridium botulinum and Clostridium perfringens
|
8
|
Clostridium difficile
|
9
| Congenital infections: Toxoplasma, rubella, cytomegalovirus and parvovirus B19 |
10
|
Corynebacterium diphteriae
|
11
|
Coxiella burnetii, Rickettsia, Anaplasma (Ehrlichia)
|
12
|
Enterococci
|
13
| Enteroviruses including polioviruses and parechoviruses |
14
| ESBL + Carbapenemase producing Enterobacteriaceae
|
15
|
Haemophilus influenzae
|
16
| Hantavirus |
17
|
Helicobacter pylori
|
18
| Hepatitis B, C, D and E viruses |
19
| Influenza virus |
20
|
Legionella pneumophila
|
21
|
Listeria monocytogenes
|
22
| Measles virus + rubella |
23
|
Mycobacterium spp. |
24
| Mycosis |
25
|
Neisseria meningitidis
|
26
| Noroviruses |
27
| Rabies virus |
28
| Respiratory pathogens: adenovirus, coronavirus including SARS, human parainfluenza virus, Mycoplasma pneumoniae, Chlamydia pneumoniae, respiratory syncytial virus (RSV), human metapneumovirus (HMPV) |
29
| Rotavirus |
30
|
Salmonella/Shigella spp. |
31
| Shiga-toxins producing E. coli (STEC) |
32
|
Staphylococcus aureus
|
33
| STI: Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae
|
34
|
Streptococcus agalactiae
|
35
|
Streptococcus pneumoniae invasive |
36
|
Streptococcus pyogenes invasive |
37
| Tick-borne encephalitis |
38
|
Vibrio cholerae and Vibrio parahaemolyticus
|
39
| West Nile virus (arboviruses) |
40
|
Yersinia enterocolitica and Yersinia pseudotuberculosis
|